We are live on ! Find out more
RLYB icon

Rallybio

59 hedge funds and large institutions have $188M invested in Rallybio in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

11% more funds holding

Funds holding: 5359 (+6)

3% more capital invested

Capital invested by funds: $183M → $188M (+$4.87M)

0.47% more ownership

Funds ownership: 10.54%11.01% (+0.47%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
59
Holders Change
+6
Holders Change %
+11.32%
% of All Funds
0.93%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
11
Increased
23
Reduced
10
Closed
5
Calls
Puts
Net Calls
Net Calls Change

RLYB Hedge Fund Activity: Q2 2023 in Review

59 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q2 2023, worth a combined $188M — up 2.7% from $183M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RLYB positions and 5 closed out — a net gain of 6 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $4.42M. The largest seller was CHI Advisors, cutting an estimated $1.33M.

  • 59 institutional investors held Rallybio (RLYB) as of Q2 2023, up from 53 in Q1 2023.
  • Funds reported $188M of Rallybio stock for Q2 2023, up 2.7% quarter-over-quarter.
  • 11 funds opened new Rallybio positions in Q2 2023 and 5 closed out, a net change of +6 holders.
  • The largest Rallybio buyer in Q2 2023 was BlackRock, an estimated $4.42M added.
  • The largest Rallybio seller in Q2 2023 was CHI Advisors, an estimated $1.33M sold.

Based on aggregated 13F filings for Q2 2023.